LNA Santé SA
EPA:LNA.PA
25.55 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 736.085 | 728.224 | 689.492 | 573.893 | 527.86 | 538.761 | 486.671 | 475.017 | 424.818 | 356.174 | 324.17 | 258.876 | 221.574 | 206.208 | 201.861 |
Cost of Revenue
| 653.375 | 105.8 | 111.622 | 92.862 | 84.496 | 132.951 | 102.949 | 105.785 | 90.499 | 71.8 | 84.045 | 55.483 | 38.296 | 37.772 | 47.158 |
Gross Profit
| 82.71 | 622.424 | 577.87 | 481.031 | 443.364 | 405.81 | 383.722 | 369.232 | 334.319 | 284.374 | 240.125 | 203.393 | 183.278 | 168.436 | 154.703 |
Gross Profit Ratio
| 0.112 | 0.855 | 0.838 | 0.838 | 0.84 | 0.753 | 0.788 | 0.777 | 0.787 | 0.798 | 0.741 | 0.786 | 0.827 | 0.817 | 0.766 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 90.207 | 86.851 | 81.667 | 66.729 | 58.831 | 107.658 | 101.73 | 93.96 | 88.647 | 76.659 | 65.315 | 55.861 | 0 | 0 | 0 |
Selling & Marketing Expenses
| -89.857 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.819 | 43.47 | 41.935 |
SG&A
| 0.35 | 86.851 | 81.667 | 66.729 | 58.831 | 107.658 | 101.73 | 93.96 | 88.647 | 76.659 | 65.315 | 55.861 | 49.819 | 43.47 | 41.935 |
Other Expenses
| -17.394 | 480.476 | 437.343 | 367.214 | 330.341 | 256.065 | 241.679 | 239.04 | 213.295 | 186.812 | 150.598 | 128.942 | 116.673 | 107.749 | 99.558 |
Operating Expenses
| 17.744 | 567.327 | 519.01 | 433.943 | 389.172 | 363.723 | 343.409 | 333 | 301.942 | 263.471 | 215.913 | 184.803 | 166.492 | 151.219 | 141.493 |
Operating Income
| 64.966 | 63.779 | 55.812 | 37.08 | 54.508 | 42.096 | 38.973 | 34.861 | 31.774 | 23.106 | 20.116 | 18.027 | 16.786 | 17.217 | 13.21 |
Operating Income Ratio
| 0.088 | 0.088 | 0.081 | 0.065 | 0.103 | 0.078 | 0.08 | 0.073 | 0.075 | 0.065 | 0.062 | 0.07 | 0.076 | 0.083 | 0.065 |
Total Other Income Expenses Net
| -27.649 | -20.6 | -19.561 | -18.438 | -18.062 | -6.391 | -7.823 | -8.234 | -9.627 | -13.366 | -6.635 | -5.04 | -3.187 | -3.426 | -3.825 |
Income Before Tax
| 37.317 | 43.179 | 36.251 | 18.642 | 36.446 | 35.705 | 31.15 | 26.627 | 22.147 | 9.74 | 13.481 | 12.987 | 13.599 | 13.791 | 9.385 |
Income Before Tax Ratio
| 0.051 | 0.059 | 0.053 | 0.032 | 0.069 | 0.066 | 0.064 | 0.056 | 0.052 | 0.027 | 0.042 | 0.05 | 0.061 | 0.067 | 0.046 |
Income Tax Expense
| 13.022 | 15.914 | 14.585 | 10.205 | 14.759 | 13.267 | 6.001 | 3.878 | 10.712 | 2.702 | 5.639 | 6.556 | 5.063 | 5.552 | 3.19 |
Net Income
| 23.409 | 25.813 | 23.51 | 7.807 | 20.828 | 21.525 | 24.221 | 21.622 | 10.623 | 7.031 | 7.715 | 6.225 | 8.31 | 8.239 | 6.195 |
Net Income Ratio
| 0.032 | 0.035 | 0.034 | 0.014 | 0.039 | 0.04 | 0.05 | 0.046 | 0.025 | 0.02 | 0.024 | 0.024 | 0.038 | 0.04 | 0.031 |
EPS
| 2.29 | 2.49 | 2.45 | 0.81 | 2.16 | 2.23 | 2.5 | 2.4 | 1.2 | 0.83 | 0.91 | 0.73 | 0.97 | 0.94 | 0.74 |
EPS Diluted
| 2.29 | 2.49 | 2.45 | 0.81 | 2.16 | 2.23 | 2.5 | 2.4 | 1.2 | 0.83 | 0.91 | 0.73 | 0.97 | 0.94 | 0.74 |
EBITDA
| 147.438 | 148.317 | 139.507 | 117.844 | 113.861 | 52.961 | 51.858 | 47.64 | 44.391 | 45.455 | 35.754 | 23.699 | 21.785 | 22.308 | 19.915 |
EBITDA Ratio
| 0.2 | 0.204 | 0.202 | 0.205 | 0.216 | 0.098 | 0.107 | 0.1 | 0.104 | 0.128 | 0.11 | 0.092 | 0.098 | 0.108 | 0.099 |